Solvonis Therapeutics plc (LON:SVNS)
London
· Delayed Price · Currency is GBP · Price in GBX 0.1650
+0.0200 (13.79%)
At close: May 9, 2025, 4:30 PM BST
Solvonis Therapeutics Employees
Solvonis Therapeutics had 3 employees as of December 31, 2024. The number of employees decreased by 4 or -57.14% compared to the previous year.
Employees
3
Change (1Y)
-4
Growth (1Y)
-57.14%
Revenue / Employee
n/a
Profits / Employee
-530.00K GBP
Market Cap
3.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3 | -4 | -57.14% |
| Dec 31, 2023 | 7 | -2 | -22.22% |
| Dec 31, 2022 | 9 | -1 | -10.00% |
| Dec 31, 2021 | 10 | 1 | 11.11% |
| May 31, 2020 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| HSBC Holdings | 211,304 |
| Shell | 96,000 |
| Unilever | 115,964 |
| Rio Tinto Group | 60,000 |
| RELX PLC | 36,400 |
| British American Tobacco p.l.c. | 48,989 |
| Rolls-Royce Holdings | 42,400 |